As shown in Table 2, 7/10 miRNAs studied here were more strongly expressed in glioma IDH1/2-WT (expression > 100) than in non-tumor brain tissue, while only 2/10 miRNAs were more strongly expressed in glioma IDH1/2-MUT than in non-tumor brain tissue. This evidence concerns the gene IDH1 and central nervous system cancer.